Pui Seto Selected Research

Neoplasms (Cancer)

1/2022	Regression of EGFR positive established solid tumors in mice with the conditionally active T cell engager TAK-186.
1/2021	TriTACs, a Novel Class of T-Cell-Engaging Protein Constructs Designed for the Treatment of Solid Tumors.
1/2020	COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors.
1/2010	Antibodies to TWEAK receptor inhibit human tumor growth through dual mechanisms.
11/2007	A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pui Seto Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 11/2007
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Schizophrenia (Dementia Praecox) 05/2013
1	Mental Disorders (Mental Disorder) 05/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2013
1	Dystonia (Limb Dystonia) 05/2013
1	Parkinson Disease (Parkinson's Disease) 05/2013
1	Mood Disorders (Mood Disorder) 05/2013
1	Inflammation (Inflammations) 01/2012
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2007
1	Carcinoma (Carcinomatosis) 11/2007
1	Melanoma (Melanoma, Malignant) 11/2007

Drug/Important Bio-Agent (IBA)

2	AntigensIBA 01/2022 - 01/2020
2	Surface Antigens (Surface Antigen)IBA 01/2022 - 01/2021
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2013
1	ProdrugsIBA 01/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Serum AlbuminIBA 01/2020
1	BuffersIBA 05/2013
1	CatecholaminesIBA 05/2013
1	Dopamine (Intropin)FDA LinkGeneric 05/2013
1	EnzymesIBA 05/2013
1	ImmunosorbentsIBA 05/2013
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 05/2013
1	SynucleinsIBA 05/2013
1	Laminin (Merosin)IBA 01/2012
1	AntibodiesIBA 01/2010
1	LigandsIBA 01/2010
1	TWEAK ReceptorIBA 01/2010
1	enavatuzumabIBA 01/2010
1	Monoclonal AntibodiesIBA 01/2010
1	Immunoglobulin G (IgG)IBA 01/2010
1	Complementary DNA (cDNA)IBA 01/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2007
1	volociximabIBA 11/2007
1	IntegrinsIBA 11/2007
1	Integrin alpha5beta1IBA 11/2007

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2010
1	Castration 01/2021